Evidence map›Paper›PMID 38648756›Full record

ArticleRheumatology (Oxford, England)2024

ChatGPT4's proficiency in addressing patients' questions on systemic lupus erythematosus: a blinded comparative study with specialists.

Dan Xu, Jinxia Zhao, Rui Liu, Yijun Dai, Kai Sun, Priscilla Wong, Samuel Lee Shang Ming, Koh Li Wearn, Jiangyuan Wang, Shasha Xie and 3 more

Open access · greenAbstract readComparative Study
In one paragraph

Article in Rheumatology (Oxford, England), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Observational
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 4 countries.

Dan XuDepartment of Rheumatology and Immunology, Peking University Third Hospital, Beijing, China.ORCID 0000-0002-6367-9132
Jinxia ZhaoDepartment of Rheumatology and Immunology, Peking University Third Hospital, Beijing, China.
Rui LiuDepartment of Rheumatology and Immunology, Peking University Third Hospital, Beijing, China.
Yijun DaiDepartment of Rheumatology and Immunology, Fujian Provincial Hospital, Fuzhou, China.
Kai SunDepartment of Medicine, Division of Rheumatology and Immunology, Duke University, Durham, North Carolina, USA.
Priscilla WongDepartment of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China.
Samuel Lee Shang MingDepartment of Rheumatology, Allergy and Immunology, Tan Tock Seng Hospital, Singapore, Singapore.
Koh Li WearnDepartment of Rheumatology, Allergy and Immunology, Tan Tock Seng Hospital, Singapore, Singapore.
Jiangyuan WangBeijing Kidney Health Technology Co., Ltd, Beijing, China.
Shasha XieBeijing Kidney Health Technology Co., Ltd, Beijing, China.
Lin ZengResearch Center of Clinical Epidemiology, Peking University Third Hospital, Beijing, China.
Rong MuDepartment of Rheumatology and Immunology, Peking University Third Hospital, Beijing, China.
Chuanhui XuDepartment of Rheumatology, Allergy and Immunology, Tan Tock Seng Hospital, Singapore, Singapore.ORCID 0000-0002-3222-7168
Peking University · CNTan Tock Seng Hospital · SGChinese University of Hong Kong · HKDuke University · USFujian Provincial Hospital · CNNanyang Technological University · SG

Funding

Institutional Career Development CoreKL2TR002554 · NCATS · DUKE UNIVERSITY · PI SVETKEY, LAURA P · 2018 to 2022
$8.2M
American Heart Association COVID-19 Fund to Retain Clinical Scientists 923717National Natural Science Foundation of China 82271836NCATS NIH HHS KL2 TR002554NHG-LKCMedicine Clinician-Scientist Career Scheme CSCS-22-02-01NIH HHS 1KL2TR002554NMRC Clinician-Scientist Individual Research MOH-001374
6 · The paper itself

Abstract

objectivesThe efficacy of artificial intelligence (AI)-driven chatbots like ChatGPT4 in specialized medical consultations, particularly in rheumatology, remains underexplored. This study compares the proficiency of ChatGPT4' responses with practicing rheumatologists to inquiries from patients with SLE.

methodsIn this cross-sectional study, we curated 95 frequently asked questions (FAQs), including 55 in Chinese and 40 in English. Responses for FAQs from ChatGPT4 and five rheumatologists were scored separately by a panel of rheumatologists and a group of patients with SLE across six domains (scientific validity, logical consistency, comprehensibility, completeness, satisfaction level and empathy) on a 0-10 scale (a score of 0 indicates entirely incorrect responses, while 10 indicates accurate and comprehensive answers).

resultsRheumatologists' scoring revealed that ChatGPT4-generated responses outperformed those from rheumatologists in satisfaction level and empathy, with mean differences of 0.537 (95% CI, 0.252-0.823; P < 0.01) and 0.460 (95% CI, 0.227-0.693; P < 0.01), respectively. From the SLE patients' perspective, ChatGPT4-generated responses were comparable to the rheumatologist-provided answers in all six domains. Subgroup analysis revealed ChatGPT4 responses were more logically consistent and complete regardless of language and exhibited greater comprehensibility, satisfaction and empathy in Chinese. However, ChatGPT4 responses were inferior in comprehensibility for English FAQs.

conclusionChatGPT4 demonstrated comparable, possibly better in certain domains, to address FAQs from patients with SLE, when compared with the answers provided by specialists. This study showed the potential of applying ChatGPT4 to improve consultation in SLE patients.

Indexed as

Lupus Erythematosus, SystemicAdultArtificial IntelligenceCross-Sectional StudiesFemaleHumansMaleMiddle AgedPatient SatisfactionPhysician-Patient RelationsRheumatologistsRheumatologySurveys and QuestionnairesChatbotChatGPT4rheumatologySLE

Identifiers

PMID38648756
PMCPMC11371377
OpenAlexW4394992265

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.